MEGHAN QUIRKE: Open Payments
NPI 1891321188 · WINNETKA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,100 in 100 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $547 · 2025 $2,100
Food & beverage: $2,000Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $317 |
| ABBVIE INC. | 19 | $314 |
| Regeneron Healthcare Solutions, Inc. | 9 | $274 |
| Incyte Corporation | 9 | $209 |
| Janssen Biotech, Inc. | 12 | $200 |
| Galderma Laboratories, L.P. | 16 | $194 |
| Lilly USA, LLC | 8 | $153 |
| GENZYME CORPORATION | 4 | $144 |
| Arcutis Biotherapeutics, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $62 |
Products named: DUPIXENT, Bimzelx, OPZELURA, TREMFYA, SKYRIZI, NEMLUVIO, RINVOQ, TALTZ.
Industry payments across IL — which companies pay providers there.
